Koronis Pharmaceuticals

Koronis Pharma develops antiviral therapeutics based on a viral decay acceleration mechanism.

Koronis Pharmaceuticals, Inc., is a privately held biotechnology company developing antiviral therapeutics based on a novel mechanism, Viral Decay Accelerationâ„¢ (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV). The Company also has products in development for the treatment of hepatitis C and RSV.